| Low and medium income countries | High income countries | ||||
---|---|---|---|---|---|---|
 | BG | GR | SP | UK | NO | NL |
Adequately funded health care infrastructure | Â | Â | Â | ++ | ++ | ++ |
Existence and impact of dedicated SM policies, services, and resources | Â | Â | + | ++ | ++ | ++ |
Emphasis on nuances in SMS policies, resources, and delivery | Â | + | + | ++ | ++ | ++ |
Absence of dedicated and enacted policies related to inadequate provision, austerity, and lack of resources | ++ | ++ | + | Â | Â | Â |
Drug companies viewed in terms of playing an explicit role in SM | ++ | ++ | ++ | Â | Â | Â |
Drug companies in strong position to reinforcing biomedical focus in SM | ++ | ++ | ++ | Â | Â | Â |
Focus on promoting SM at an individual level | Â | Â | Â | ++ | + | ++ |
Behavioural interventions introduced by primary care services | Â | Â | Â | ++ | ++ | ++ |
Presence of cycling-friendly physical and social environment | Â | Â | Â | Â | ++ | ++ |
Expressed concerns with social rights & socialising healthcare cost | Â | ++ | Â | ++ | ++ | Â |